Shield Therapeutics plc (STX) — Free Cash Flow Generation Index
Latest as of June 2020:
1.00x
Shield Therapeutics plc (STX) has a Free Cash Flow Generation Index of 1.00x as of June 2020. Free cash flow of GBX2.39 Million represents 1% of operating cash flow (GBX2.40 Million). See Shield Therapeutics plc (STX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
GBX2.39 Million
GBX
Operating Cash Flow
GBX2.40 Million
GBX
Capital Expenditures
GBX2.00K
GBX
Annual Free Cash Flow Generation for Shield Therapeutics plc (None–None)
Year-by-year Free Cash Flow Generation Index for Shield Therapeutics plc. For the full company profile including market capitalisation, see market cap of Shield Therapeutics plc.
| Year | FCG Index | Free Cash Flow (GBX) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).